# | Drug | Count |
---|---|---|
0 | NIRAPARIB | 127 |
1 | PEMBROLIZUMAB | 77 |
2 | DEXAMETHASONE | 68 |
3 | DEXAMETHASONE 1.5 MG | 68 |
4 | BEVACIZUMAB | 64 |
5 | CARBOPLATIN | 51 |
6 | RIBOCICLIB | 50 |
7 | LEVETIRACETAM | 41 |
8 | PACLITAXEL | 41 |
9 | TEMOZOLOMIDE | 33 |
# | Drug | Count | Frequency |
---|---|---|---|
0 | AMCINONIDE | 1 | 0.0123 |
1 | NIRAPARIB | 127 | 0.0086 |
2 | ENASIDENIB MESYLATE | 15 | 0.0072 |
3 | SILTUXIMAB | 2 | 0.0068 |
4 | RIBOCICLIB | 50 | 0.0038 |
5 | ADO-TRASTUZUMAB EMTANSINE | 16 | 0.0032 |
6 | ENFORTUMAB VEDOTIN | 3 | 0.0027 |
7 | BRIGATINIB | 5 | 0.0026 |
8 | LEVOLEUCOVORIN | 3 | 0.0025 |
9 | TEMOZOLOMIDE | 33 | 0.0022 |
# | Drug class | Count |
---|---|---|
0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 132 |
1 | Corticosteroid [EPC] | 100 |
2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 93 |
3 | Kinase Inhibitor [EPC] | 81 |
4 | Platinum-based Drug [EPC] | 75 |
5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 65 |
6 | Aromatase Inhibitor [EPC] | 60 |
7 | Alkylating Drug [EPC] | 58 |
8 | Microtubule Inhibitor [EPC] | 53 |
9 | Nucleoside Metabolic Inhibitor [EPC] | 42 |
# | Drug class | Count | Frequency |
---|---|---|---|
0 | Interleukin-6 Antagonist [EPC] | 2 | 0.0068 |
1 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 132 | 0.0054 |
2 | Estrogen Receptor Antagonist [EPC] | 25 | 0.0012 |
3 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 5 | 0.0011 |
4 | Programmed Death Ligand-1 Blocker [EPC] | 9 | 0.0010 |
5 | Aromatase Inhibitor [EPC] | 60 | 0.0007 |
6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 93 | 0.0007 |
7 | HER2/neu Receptor Antagonist [EPC] | 29 | 0.0006 |
8 | Microtubule Inhibitor [EPC] | 53 | 0.0005 |
9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 65 | 0.0005 |